Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
456 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
Rank Status Study
21 Completed A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: rosiglitazone
22 Withdrawn Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: IMM 124-E;   Biological: Placebo
23 Active, not recruiting Study of NGM282 in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: NGM282;   Other: Placebo
24 Recruiting Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: solithromycin
25 Withdrawn Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: pentoxiphylline and Vitamin E;   Drug: Vitamin E
26 Active, not recruiting A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: BMS-986036;   Drug: Placebo
27 Withdrawn Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: Vitamin E plus Pentoxiphyllin;   Drug: Vitamin E
28 Completed The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: synbiotic;   Other: placebo
29 Completed Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: GS-9450;   Drug: GS-9450 Placebo
30 Unknown  The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: S-adenosylmethionine (SAMe);   Drug: pentoxiphylline (PTX)
31 Completed A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: ASP9831;   Drug: Placebo
32 Completed Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GFT505 80mg;   Drug: GFT505 120mg;   Drug: Placebo
33 Completed The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis;   Increased Iron Storage / Disturbed Distribution
Intervention: Drug: Exjade
34 Recruiting GS-0976 in Adults With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-0976;   Drug: Placebo
35 Active, not recruiting Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
36 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions: Drug: Elafibranor;   Drug: Placebo
37 Recruiting A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis (NASH)
Interventions: Biological: IMM-124E;   Other: Placebo
38 Completed Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
39 Recruiting Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
40 Completed Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-4997;   Biological: SIM

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.